Oliver Fetzer
Member of the Compensation Committee
General Science
TECAN
Spain
Biography
Education MBA (Carnegie Mellon University, Pittsburgh, PA, USA), Ph.D. Pharmaceutical Sciences (Major: Medicinal Chemistry, University of South Carolina, USA) Professional background Since 2014 CEO Synthetic Genomics 2009 - 2014 Cerulean Pharma Inc., USA, President and Chief Executive Officer, Member of the Board of Directors 2007 - 2008 Sabbatical 2002 - 2007 Cubist Pharmaceuticals, USA, various management positions, including Senior Vice President, Corporate Development and Research and Development 1993 - 2002 The Boston Consulting Group, USA, between 2000 and 2002 Managing Director and Partner, Boston Other activities Synthetic Genomics, member of the Board
Research Interest
General Science
